MZT2A (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K31-ub
KLALRRKkVLstEEM
0 1
MZT2A (human) KLALRRKkVLstEEM K31-ub
S34-p
LRRKkVLstEEMELY
0 18
MZT2A (human) LRRKkVLstEEMELY S34-p
T35-p
RRKkVLstEEMELYE
0 13
MZT2A (human) RRKkVLstEEMELYE T35-p
K110-ub
PETRGRDkGSAALGG
0 1
MZT2A (human) PETRGRDkGSAALGG K110-ub
S130-p
ERSNHEGsSQrMPrQ
0 1
MZT2A (human) ERSNHEGsSQrMPrQ S130-p
R133-m1
NHEGsSQrMPrQPsA
0 1
MZT2A (human) NHEGsSQrMPrQPsA R133-m1
R136-m1
GsSQrMPrQPsATRL
0 1
MZT2A (human) GsSQrMPrQPsATRL R136-m1
S139-p
QrMPrQPsATRLPKG
Upstream
0 26
Treatment
  • nocodazole
MZT2A (human) QrMPrQPsATRLPKG S139-p
S152-p
KGGGPGKsPtQGSt_
0 11
MZT2A (human) KGGGPGKsPtQGSt_ S152-p
T154-p
GGPGKsPtQGSt___
0 1
MZT2A (human) GGPGKsPtQGSt___ T154-p
T158-p
KsPtQGSt_______
0 1
MZT2A (human) KsPtQGSt_______ T158-p